Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Clinical Immunology
|
September 19, 2009
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis
Sara A J Thompson, Joanne L Jones, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 2011
Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy
Jacob D Kattan, George N Konstantinou, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 18, 2023
Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy
Ashley Sang Eun Lee, Mary Grace Baker, Amanda L Cox, et al.
The Psychiatric Clinics of North America
|
March 2, 2015
Mental health and quality-of-life concerns related to the burden of food allergy
Noga L Ravid, Ronen Arnon Annunziato, Michael A Ambrose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 10, 2025
Sesame oral immunotherapy outcomes in a pediatric cohort
Ami Shah, Amanda L Cox, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Peanut-induced food protein-induced enterocolitis syndrome (FPIES) in infants with early peanut introduction
Joao Pedro Lopes, Amanda L Cox, Mary Grace Baker, et al.
European Journal of Immunology
|
October 19, 2005
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Amanda L Cox, Sara A J Thompson, Joanne L Jones, et al.
Journal of Neuroimmunology
|
April 8, 2014
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis
J William L Brown, Peter J Martin, John W Thorpe, et al.
The Journal of Clinical Investigation
|
June 24, 2009
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
Joanne L Jones, Chia-Ling Phuah, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 11, 2022
Successful baked egg and baked milk oral immunotherapy in a pediatric cohort
Shouling Zhang, Jacob D Kattan, Mary Grace Baker, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Clinical Immunology
|
September 19, 2009
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis
Sara A J Thompson, Joanne L Jones, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 2011
Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy
Jacob D Kattan, George N Konstantinou, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 18, 2023
Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy
Ashley Sang Eun Lee, Mary Grace Baker, Amanda L Cox, et al.
The Psychiatric Clinics of North America
|
March 2, 2015
Mental health and quality-of-life concerns related to the burden of food allergy
Noga L Ravid, Ronen Arnon Annunziato, Michael A Ambrose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 10, 2025
Sesame oral immunotherapy outcomes in a pediatric cohort
Ami Shah, Amanda L Cox, Marion Groetch, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Peanut-induced food protein-induced enterocolitis syndrome (FPIES) in infants with early peanut introduction
Joao Pedro Lopes, Amanda L Cox, Mary Grace Baker, et al.
European Journal of Immunology
|
October 19, 2005
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Amanda L Cox, Sara A J Thompson, Joanne L Jones, et al.
Journal of Neuroimmunology
|
April 8, 2014
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis
J William L Brown, Peter J Martin, John W Thorpe, et al.
The Journal of Clinical Investigation
|
June 24, 2009
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
Joanne L Jones, Chia-Ling Phuah, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 11, 2022
Successful baked egg and baked milk oral immunotherapy in a pediatric cohort
Shouling Zhang, Jacob D Kattan, Mary Grace Baker, et al.
Page
of 3